John Lechleiter has been named the new CEO of Eli Lilly, reports the Wall Street Journal, and Derek Lowe thinks that's unusual (but still cool) because Lechleiter's a researcher who worked his way up from the bench to management. Lowe ponders why that doesn't happen more often in pharma. One reason is that a lot of scientists don't want to be managers. Another is that "scientists, taken as a class, do not always turn into the best managers," Lowe says. "Putting it delicately, there are a number of personality types reasonably well-suited for science, but not so well-suited for supervising and developing other people."
Which Do You Prefer -- Titrations or PowerPoint Presentations?
Jan 04, 2008